According to the data that REP1knockdown sensitizes cancer cells, especially under nutrient-deprivation conditions, we hypothesized that target of rapamycin (TOR) signaling can be closely related to REP1-mediated cell growth and survival to sustain metabolic stress conditions. The gene discussed is CHM; the disease is cancer.